Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ICUCW
Upturn stock ratingUpturn stock rating

LMF Acquisition Opportunities Inc (ICUCW)

Upturn stock ratingUpturn stock rating
$0.02
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: ICUCW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$0.02
high$

Analysis of Past Performance

Type Stock
Historic Profit -15%
Avg. Invested days 24
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -0.86
52 Weeks Range 0.02 - 0.11
Updated Date 05/24/2025
52 Weeks Range 0.02 - 0.11
Updated Date 05/24/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1304.44%

Management Effectiveness

Return on Assets (TTM) -144.37%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 9810025
Shares Outstanding -
Shares Floating 9810025
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

LMF Acquisition Opportunities Inc

stock logo

Company Overview

overview logo History and Background

LMF Acquisition Opportunities Inc. (LMAO) is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It was founded in 2020.

business area logo Core Business Areas

  • SPAC Formation: LMAO's primary business involves identifying and acquiring a private company with high growth potential. It does not have operations of its own, but rather seeks to merge with another operating company to take it public.

leadership logo Leadership and Structure

The leadership team consists of experienced investment professionals specializing in mergers and acquisitions. Structure typically follows a board of directors overseeing a management team tasked with identifying target companies.

Top Products and Market Share

overview logo Key Offerings

  • SPAC IPO: LMAO's initial offering is its own IPO. This is used to raise capital in order to acquire a target company. Competitors include other SPACs looking to acquire companies in various sectors. Market share is difficult to quantify because the sector is acquisition based.

Market Dynamics

industry overview logo Industry Overview

The SPAC market is highly competitive and sensitive to investor sentiment. Recent regulatory scrutiny has increased due diligence requirements and cooled the market somewhat. There is large number of SPACs searching for viable targets.

Positioning

LMAO is positioned to identify an attractive acquisition target within a high-growth sector, allowing the acquired company to become publicly listed. Their competitive advantages will depend on the team's ability to conduct due diligence and get the deal done.

Total Addressable Market (TAM)

The TAM depends on the industry targeted for acquisition. It could be a multi-billion dollar market depending on the target sector. LMAO is seeking to gain a dominant position in the target area through its acquisition.

Upturn SWOT Analysis

Strengths

  • Experienced management team
  • Access to public market capital
  • Flexibility to pursue diverse acquisition targets

Weaknesses

  • No operating history
  • Dependence on finding suitable acquisition target
  • Time-sensitive mandate (SPACs have limited time to complete a deal)

Opportunities

  • Acquisition of a high-growth company in an attractive sector
  • Capitalizing on market volatility to find undervalued targets
  • Creating shareholder value through successful acquisition and integration

Threats

  • Increased regulatory scrutiny of SPAC transactions
  • Intense competition for attractive acquisition targets
  • Economic downturn impacting target company performance
  • Inability to find suitable target within the required timeframe.

Competitors and Market Share

competitor logo Key Competitors

  • None - Before Merger

Competitive Landscape

Prior to an acquisition, competition revolves around attracting investor capital and securing a deal with a desirable target. Competitive advantages depend on the management team's experience and network.

Growth Trajectory and Initiatives

Historical Growth: Growth is not applicable prior to an acquisition.

Future Projections: Future growth depends entirely on the acquired company's performance and integration strategy. No reliable projections exist prior to the deal.

Recent Initiatives: Recent initiatives revolve around identifying and evaluating potential acquisition targets.

Summary

LMF Acquisition Opportunities Inc. is a special purpose acquisition company in search of a suitable company to acquire. Success hinges on their capacity to secure favorable acquisition terms, manage integration effectively, and propel long-term growth. Like all SPACs, the company needs to be quick to secure an acquisition before running out of time. Potential for downside exists if the target company performs poorly after the merger, or the deal falls apart entirely.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Website

Disclaimers:

This analysis is based on publicly available information and is not financial advice. Investment in SPACs is highly speculative and involves significant risk.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About LMF Acquisition Opportunities Inc

Exchange NASDAQ
Headquaters Denver, CO, United States
IPO Launch date 2021-03-18
CEO, President & Executive Director Mr. Eric Schlorff
Sector Healthcare
Industry Biotechnology
Full time employees 19
Full time employees 19

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.